Literature DB >> 22260097

Relationship between depression and proinflammatory cytokine levels in hemodialysis patients.

Havva Cilan1, Nilufer Oguzhan, Aydin Unal, Tayfun Turan, Ayse Nedret Koc, Murat Hayri Sipahioglu, Cengiz Utas, Oktay Oymak.   

Abstract

AIM: To evaluate the presence of the relationship between depression and proinflammatory cytokine levels in hemodialysis (HD) patients.
METHODS: The study included 40 HD patients and 20 healthy controls. All participants were evaluated for the presence of depression using the structured clinical interview based on criteria defined by Diagnostic and statistical manual mental disorders (Fourth Edition, Text Revision) Axis I disorders. The severity of depressive symptoms was assessed using the Beck Depression Inventory, the Hamilton Depression Rating Scale, and the Hamilton Anxiety Rating Scale. The depressive patients received antidepressants for 8 weeks. Blood samples were taken at baseline and after 8 weeks of antidepressant treatment for interleukin-1 (IL-1), IL-6, and tumor necrosis factor-α (TNF-α) levels.
RESULTS: A total of 9 (22.5%) of the 40 HD patients had depression. IL-1, IL-6, and TNF-α levels were significantly higher in HD patients compared with that in the control group, but were not significantly different between HD patients with and without depression. In the depressive patients, we observed no significant difference in proinflammatory cytokine levels after antidepressant treatment. The psychometric measurements in depressive patients decreased significantly after antidepressant treatment.
CONCLUSION: We observed that depression is a common psychiatric disorder and has no significant effect on proinflammatory cytokine levels in HD patients; no important improvement in cytokine levels was observed after antidepressant therapy.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22260097     DOI: 10.3109/0886022X.2011.647292

Source DB:  PubMed          Journal:  Ren Fail        ISSN: 0886-022X            Impact factor:   2.606


  7 in total

1.  Anhedonia as a clinical correlate of inflammation in adolescents across psychiatric conditions.

Authors:  Rachel D Freed; Lushna M Mehra; Daniel Laor; Manishkumar Patel; Carmen M Alonso; Seunghee Kim-Schulze; Vilma Gabbay
Journal:  World J Biol Psychiatry       Date:  2018-08-16       Impact factor: 4.132

2.  Depression and the Effect of Sertraline on Inflammatory Biomarkers in Patients with Nondialysis CKD.

Authors:  L Parker Gregg; Thomas Carmody; Dustin Le; Nina Bharadwaj; Madhukar H Trivedi; S Susan Hedayati
Journal:  Kidney360       Date:  2020-04-13

3.  Inflammatory cytokines in major depressive disorder: A case-control study.

Authors:  Paolo Cassano; Eric Bui; Andrew H Rogers; Zandra E Walton; Rachel Ross; Mary Zeng; Mireya Nadal-Vicens; David Mischoulon; Amanda W Baker; Aparna Keshaviah; John Worthington; Elizabeth A Hoge; Jonathan Alpert; Maurizio Fava; Kwok K Wong; Naomi M Simon
Journal:  Aust N Z J Psychiatry       Date:  2016-09-29       Impact factor: 5.744

4.  Depressive symptoms but not chronic pain have an impact on the survival of patients undergoing maintenance hemodialysis.

Authors:  Mariusz Kusztal; Ewa Trafidło; Katarzyna Madziarska; Hanna Augustyniak-Bartosik; Maciej Karczewski; Waclaw Weyde; Magdalena Krajewska; Joanna Rymaszewska; Marian Klinger
Journal:  Arch Med Sci       Date:  2016-05-09       Impact factor: 3.318

5.  A Systematic Review and Meta-Analysis of Depression and Protein-Energy Wasting in Kidney Disease.

Authors:  L Parker Gregg; Thomas Carmody; Dustin Le; Gerard Martins; Madhukar Trivedi; S Susan Hedayati
Journal:  Kidney Int Rep       Date:  2019-12-21

6.  Major depressive disorders in chronic hemodialysis patients in Nazareth: identification and assessment.

Authors:  Zaher Armaly; Joseph Farah; Adel Jabbour; Bishara Bisharat; Amir Abd-El Qader; Shahira Saba; Maha Zaher; Elia El Haj; Munir Hamzi; Abdalla Bowirrat
Journal:  Neuropsychiatr Dis Treat       Date:  2012-07-25       Impact factor: 2.570

7.  Depression, quality of life, and body composition in patients with end-stage renal disease: a cohort study.

Authors:  Annerose Barros; Bartira E da Costa; Claudio C Mottin; Domingos O d'Avila
Journal:  Braz J Psychiatry       Date:  2016-02-05       Impact factor: 2.697

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.